Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Shafer

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 16, 2011
Ischemic stroke in the setting of chronic immune thrombocytopenia in an elderly patient--a therapeutic dilemmaAnna De La Peña, Jawed Fareed, Indermohan Thethi, et al.
Leukemia Research|August 24, 2013
Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphomaDanielle Shafer, Mitchell R Smith, Hossein Borghaei, et al.
Cancer Chemotherapy and Pharmacology|January 17, 2025
A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndromeKeri R Maher, Danielle Shafer, Dale Schaar, et al.
Cancer Chemotherapy and Pharmacology|March 2, 2023
Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignanciesDanielle Shafer, Amanda B Kagan, Michelle A Rudek, et al.
JCO Oncology Practice|April 1, 2021
Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot StudyMary Steimer, Jessica Leabo, Hongkun Wang, et al.
Leukemia & Lymphoma|December 28, 2020
Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndromeBeata Holkova, Danielle Shafer, Victor Yazbeck, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2018
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell LymphomaVictor Yazbeck, Danielle Shafer, Edward B Perkins, et al.
Blood Advances|February 11, 2026
ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia in Adolescents and Young AdultsAdam S DuVall, Jennifer McNeer, Matthew C Cheung, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 16, 2011
Ischemic stroke in the setting of chronic immune thrombocytopenia in an elderly patient--a therapeutic dilemmaAnna De La Peña, Jawed Fareed, Indermohan Thethi, et al.
Leukemia Research|August 24, 2013
Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphomaDanielle Shafer, Mitchell R Smith, Hossein Borghaei, et al.
Cancer Chemotherapy and Pharmacology|January 17, 2025
A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndromeKeri R Maher, Danielle Shafer, Dale Schaar, et al.
Cancer Chemotherapy and Pharmacology|March 2, 2023
Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignanciesDanielle Shafer, Amanda B Kagan, Michelle A Rudek, et al.
JCO Oncology Practice|April 1, 2021
Remote Home Monitoring of Patients With Cancer During the COVID Pandemic: A Pilot StudyMary Steimer, Jessica Leabo, Hongkun Wang, et al.
Leukemia & Lymphoma|December 28, 2020
Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndromeBeata Holkova, Danielle Shafer, Victor Yazbeck, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2018
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell LymphomaVictor Yazbeck, Danielle Shafer, Edward B Perkins, et al.
Blood Advances|February 11, 2026
ASH 2026 Guidelines for Frontline Management of Acute Lymphoblastic Leukemia in Adolescents and Young AdultsAdam S DuVall, Jennifer McNeer, Matthew C Cheung, et al.
Pageof 2